The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
A census of human cancer genes
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Focusing on cancer census genes [28], we observed such complex expression patterns for 26 of the current 513 cancer census genes (Additional file 1: Table S2).”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [28]
In the citing paper
“We noted that many of the boundaries of cancer driver genes were altered in specific histological subtypes (Fig. 3a, Supplementary Table 2).”
From Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (2020) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pfam Protein Families Database
Bateman, A. G. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,075
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,884
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A. U., McGreevey, L. S., Chen, C.-J., Joseph, N. E., Singer, S., Griffith, D., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,297
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R. E., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,271
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680
Self-citation
Cited by
Sorted by citations
Items 601–700 of 1,007
SMOOTH-seq: single-cell genome sequencing of human cells on a third-generation sequencing platform
Fan, X., Yang, C. Y., Li, W., Bai, X., Zhou, X., Xie, H., Wen, L., & Tang, F. (2021) · Genome biology · doi:10.1186/s13059-021-02406-y · Cited by 98
3p21.3 tumor suppressor cluster: prospects for translational applications
Ji, L., Minna, J. D., & Roth, J. A. (2005) · Future Oncology · doi:10.1517/14796694.1.1.79 · Cited by 95
Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
Parris, T. Z., Danielsson, A., Nemes, S., Kovács, A., Delle, U., Fallenius, G., Möllerström, E., Karlsson, P., & Helou, K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0889 · Cited by 96
Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer
Liu, J., McCleland, M. L., Stawiski, E. W., Gnad, F., Mayba, O., Haverty, P. M., Durinck, S., Chen, Y., Klijn, C. N., Jhunjhunwala, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4830 · Cited by 95
A chemical probe toolbox for dissecting the cancer epigenome
Shortt, J., Ott, C. J., Johnstone, R. W., & Bradner, J. E. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2016.148 · Cited by 94
Haverty, P. M., Hon, L., Kaminker, J. S., Chant, J., & Zhang, Z. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-21 · Cited by 96
Rahman, N., & Scott, R. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm026 · Cited by 95
Self-citationLiu, B., Morrison, C. D., Johnson, C. S., Trump, D. L., Qin, M., Conroy, J., Wang, J., & Liu, S. (2013) · Oncotarget · doi:10.18632/oncotarget.1537 · Cited by 96
Inference of transcriptional regulation in cancers
Jiang, P., Freedman, M. L., Liu, J. S., & Liu, X. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424272112 · Cited by 93
The Architecture of Parent-of-Origin Effects in Mice
Mott, R., Wei, Y., Kaisaki, P. J., Gan, X., Cleak, J., Edwards, A., Baud, A., & Flint, J. (2014) · Cell · doi:10.1016/j.cell.2013.11.043 · Cited by 97
Network inference in systems biology: recent developments, challenges, and applications
Saint-Antoine, M., & Singh, A. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.12.002 · Cited by 101
Human cancer databases (Review)
Pavlopoulou, A., Spandidos, D. A., & Michalopoulos, I. (2014) · Oncology Reports · doi:10.3892/or.2014.3579 · Cited by 97
Hahn, Y., Bera, T. K., Gehlhaus, K., Kirsch, I. R., Pastan, I. H., & Lee, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405490101 · Cited by 92
The sea urchin kinome: A first look
Bradham, C. A., Foltz, K. R., Beane, W. S., Arnone, M. I., Rizzo, F. M., Coffman, J. A., Mushegian, A. R., Goel, M., Morales, J., Genevière, A., et al. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.074 · Cited by 92
An integrative deep learning framework for classifying molecular subtypes of breast cancer
Mohaiminul Islam, M., Huang, S., Ajwad, R., Chi, C., Wang, Y., & Hu, P. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.005 · Cited by 90
Computational methods for identifying miRNA sponge interactions
Le, T. D., Zhang, J., Liu, L., & Li, J. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw042 · Cited by 90
RNA Editing in Pathogenesis of Cancer
Baysal, B. E., Sharma, S., Hashemikhabir, S., & Janga, S. C. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0520 · Cited by 90
Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy
Zhao, J., Dean, D. C., Hornicek, F. J., Yu, X., & Duan, Z. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.020 · Cited by 92
Structural and functional properties of genes involved in human cancer
Furney, S. J., Higgins, D. G., Ouzounis, C. A., & López-Bigas, N. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-3 · Cited by 90
The molecular basis of targeting protein kinases in cancer therapeutics
Tsai, C., & Nussinov, R. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.04.001 · Cited by 91
Computational prediction of cancer-gene function
Hu, P., Bader, G. D., Wigle, D. A., & Emili, A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2036 · Cited by 92
Do septins have a role in cancer?
Russell, S. E. H., & Hall, P. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602753 · Cited by 93
The emerging role of histone lysine demethylases in prostate cancer
Crea, F., Sun, L., Mai, A., Chiang, Y. T., Farrar, W. L., Danesi, R., & Helgason, C. D. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-52 · Cited by 90
Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma
Wang, A., Wu, L., Lin, J., Han, L., Bian, J., Wu, Y., Robson, S. C., Xue, L., Ge, Y., Sang, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03276-y · Cited by 90
RETRACTED: Selective cell death mediated by small conditional RNAs
Venkataraman, S., Dirks, R. M., Ueda, C. T., & Pierce, N. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006377107 · Cited by 89
RetractedCheng, F., Jia, P., Wang, Q., Lin, C.-C., Li, W., & Zhao, Z. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu167 · Cited by 88
Liu, C., Srihari, S., Cao, K. L., Chenevix‐Trench, G., Simpson, P. T., Ragan, M. A., & Khanna, K. K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku284 · Cited by 91
Williams, J. L., Greer, P. A., & Squire, J. A. (2014) · Cancer Genetics · doi:10.1016/j.cancergen.2014.09.003 · Cited by 88
Kaczkowski, B., Tanaka, Y., Kawaji, H., Sandelin, A., Andersson, R., Itoh, M., Lassmann, T., Hayashizaki, Y., Carninci, P., & Forrest, A. R. R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0484 · Cited by 89
Søreide, K., Nedrebø, B. S., Knapp, J.-C., Glomsaker, T. B., Søreide, J. A., & Kørner, H. (2008) · Surgical Oncology · doi:10.1016/j.suronc.2008.06.006 · Cited by 88
Human PGBD5 DNA transposase promotes site-specific oncogenic mutations in rhabdoid tumors
Henssen, A. G., Koche, R. P., Zhuang, J., Jiang, E., Reed, C., Eisenberg, A., Still, E., MacArthur, I. C., Rodríguez-Fos, E., González, S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3866 · Cited by 89
Kalathur, R. K. R., Pinto, J. P., Hernández‐Prieto, M. A., Machado, R. S. R., Almeida, D., Chaurasia, G., & Futschik, M. E. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1100 · Cited by 89
Wang, S., Li, X., Zhang, S., Gui, J., & Huang, D.-S. (2009) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2009.11.014 · Cited by 87
Algorithmic methods to infer the evolutionary trajectories in cancer progression
Caravagna, G., Graudenzi, A., Ramazzotti, D., Pamplona, R. S., Sano, L. D., Mauri, G., Moreno, V. R., Antoniotti, M., & Mishra, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520213113 · Cited by 89
Passenger Hotspot Mutations in Cancer
Hess, J. M., Bernards, A., Kim, J., Miller, M. L., Taylor-Weiner, A. N., Haradhvala, N. J., Lawrence, M. S., & Getz, G. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.08.002 · Cited by 89
Review on ethnomedicinal, phytochemical and pharmacological evidence of Himalayan anticancer plants
Tariq, A., Mussarat, S., & Adnan, M. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.02.003 · Cited by 87
van Kester, M. S., Borg, M. K., Zoutman, W. H., Out‐Luiting, J. J., Jansen, P. M., Dreef, E. J., Vermeer, M. H., van Doorn, R., Willemze, R., & Tensen, C. P. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.117 · Cited by 86
Jung, S., Kim, M. S., Jung, C. K., Park, H.-C., Kim, S. Y., Liu, J., Bae, J. S., Lee, S. H., Kim, T., Lee, S. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11922 · Cited by 86
Intrinsic Structural Disorder Confers Cellular Viability on Oncogenic Fusion Proteins
Hegyi, H., Buday, L., & Tompa, P. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000552 · Cited by 86
Identifying cancer biomarkers by network-constrained support vector machines
Chen, L., Xuan, J., Riggins, R. B., Clarke, R. C., & Wang, Y. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-161 · Cited by 87
Kubisch, J., Türei, D., Földvári-Nagy, L., Dunai, Z. A., Zsákai, L., Varga, M., Vellai, T., Csermely, P., & Korcsmáros, T. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.06.009 · Cited by 87
Bierkens, M., Krijgsman, O., Wilting, S. M., Bosch, L., Jaspers, A., Meijer, G. A., Meijer, C. J. L. M., Snijders, P. J. F., Ylstra, B., & Steenbergen, R. D. M. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22006 · Cited by 87
Need for high-resolution Genetic Analysis in iPSC: Results and Lessons from the ForIPS Consortium
Popp, B., Krumbiegel, M., Grosch, J., Sommer, A., Uebe, S., Kohl, Z., Plötz, S., Farrell, M., Trautmann, U., Kraus, C. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35506-0 · Cited by 89
Predicting and characterizing a cancer dependency map of tumors with deep learning
Chiu, Y.-C., Zheng, S., Wang, L.-J., Iskra, B. S., Rao, M. K., Houghton, P. J., Huang, Y., & Chen, Y. (2021) · Science Advances · doi:10.1126/sciadv.abh1275 · Cited by 84
“2) and those listed in the Cancer Gene Census of COSMIC (59).”
BackgroundInfluentialOncogenes and tumor suppressor genes: comparative genomics and network perspectives
Zhu, K., Liu, Q., Zhou, Y., Tao, C., Zhao, Z., Sun, J., & Xu, H. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s7-s8 · Cited by 89
Kohno, T., Otsuka, A., Girard, L., Sato, M., Iwakawa, R., Ogiwara, H., Sánchez‐Céspedes, M., Minna, J. D., & Yokota, J. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20746 · Cited by 84
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer
Liu, S., Matsuzaki, J., Wei, L., Tsuji, T., Battaglia, S., Hu, Q., Cortes, E., Wong, L.-P., Yan, L., Long, M. D., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0629-6 · Cited by 85
Unfinished Stories on Viral Quasispecies and Darwinian Views of Evolution
Más, A., López‐Galíndez, C., Cacho, I., Gómez, J., & Martı́nez, M. Á. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.02.005 · Cited by 86
Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
Foo, T. K., Tischkowitz, M. D., Simhadri, S. R., Boshari, T., Zayed, N., Burke, K. A., Berman, S. H., Blecua, P., Riaz, N., Huo, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.46 · Cited by 86
Fusco, N., Geyer, F. C., Filippo, M. R. D., Martelotto, L. G., Ng, C. K. Y., Piscuoglio, S., Guerini‐Rocco, E., Schultheis, A. M., Fuhrmann, L., Wang, L., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.134 · Cited by 85
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
Wyatt, A. W., Mo, F., Wang, K., McConeghy, B., Brahmbhatt, S., Jong, L., Mitchell, D. M., Johnston, R. L., Haegert, A., Li, E., et al. (2014) · Genome Biology · doi:10.1186/s13059-014-0426-y · Cited by 82
Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma
Riester, M., Werner, L. L., Joaquim Bellmunt, B., Selvarajah, S., Guancial, E. A., Weir, B. A., Stack, E. C., Park, R. S., O'Brien, R., Schutz, F. A. B., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0759 · Cited by 82
Integrated RNA and DNA sequencing improves mutation detection in low purity tumors
Wilkerson, M. D., Cabanski, C. R., Sun, W., Hoadley, K. A., Walter, V., Mose, L. E., Troester, M. A., Hammerman, P. S., Parker, J. S., Perou, C. M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku489 · Cited by 82
Interpretation of cancer mutations using a multiscale map of protein systems
Zheng, F., Kelly, M. R., Ramms, D. J., Heintschel, M. L., Tao, K., Tutuncuoglu, B., Lee, J. J., Ono, K., Foussard, H., Chen, M., et al. (2021) · Science · doi:10.1126/science.abf3067 · Cited by 81
A novel network control model for identifying personalized driver genes in cancer
Guo, W.-F., Zhang, S., Zeng, T., Li, Y., Gao, J., & Chen, L. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007520 · Cited by 81
Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview
Kapalatiya, H., Madav, Y., Tambe, V. S., & Wairkar, S. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01020-6 · Cited by 81
Kim, S. Y., Jung, S., Kim, M. S., Baek, I.-P., Lee, S. H., Kim, T., Chung, Y., & Lee, S. H. (2015) · Oncotarget · doi:10.18632/oncotarget.3162 · Cited by 81
Beard, B. C., Keyser, K. A., Trobridge, G. D., Peterson, L. J., Miller, D. G., Jacobs, M., Kaul, R., & Kiem, H. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.011 · Cited by 81
Hanks, S., & Rahman, N. (2004) · Cell Cycle · doi:10.4161/cc.4.2.1419 · Cited by 81
Self-citationCell type-specific properties and environment shape tissue specificity of cancer genes
Schaefer, M. H., & Serrano, L. G. (2016) · Scientific Reports · doi:10.1038/srep20707 · Cited by 82
Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression
Palaniappan, A., Ramar, K., & Ramalingam, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156665 · Cited by 81
Age-related epigenetic drift in the pathogenesis of MDS and AMLPreprint
Maegawa, S., Gough, S. M., Watanabe‐Okochi, N., Lu, Y., Zhang, N., Castoro, R. J., Estecio, M. R., Jelı́nek, J., Liang, S., Kitamura, T., et al. (2014) · Genome Research · doi:10.1101/gr.157529.113 · Cited by 83
Genomic and transcriptomic plasticity in treatment-naïve ovarian cancerPreprint
Hoogstraat, M., de Pagter, M. S., Cirkel, G. A., van Roosmalen, M. J., Harkins, T. T., Duran, K. J., Kreeftmeijer, J., Renkens, I., Witteveen, P. O., Lee, C. C., et al. (2013) · Genome Research · doi:10.1101/gr.161026.113 · Cited by 81
Cao, F., Fang, Y., Tan, H. K., Goh, Y., Choy, J. Y. H., Koh, B. T. H., Hao Tan, J., Bertin, N., Ramadass, A., Hunter, E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02257-3 · Cited by 80
Predicting cancer involvement of genes from heterogeneous data
Aragüés, R., Sander, C., & Oliva, B. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-172 · Cited by 80
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Casacuberta‐Serra, S., González-Larreategui, Í., Capitán-Leo, D., & Soucek, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01907-z · Cited by 84
Quasispecies as a matter of fact: Viruses and beyond
Ojosnegros, S., Perales, C., Más, A., & Domingo, E. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.018 · Cited by 83
Greshock, J. D., Nathanson, K. L., Martin, A., Zhang, L., Coukos, G., Weber, B. L., & Zaks, T. Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3674 · Cited by 80
PRR11 is a novel gene implicated in cell cycle progression and lung cancer
Ji, Y., Xie, M., Lan, H., Zhang, Y., Long, Y., Weng, H., Li, D., Cai, W. L., Zhu, H., Niu, Y., et al. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.12.002 · Cited by 80
Organizing knowledge to enable personalization of medicine in cancer
Good, B. M., Ainscough, B. J., McMichael, J. F., Su, A. I., & Griffith, O. L. (2014) · Genome biology · doi:10.1186/s13059-014-0438-7 · Cited by 80
Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma
Zhou, J., Wen, Q., Li, S.-F., Zhang, Y.-F., Gao, N., Tian, X., Fang, Y., Gao, J., Cui, M., He, X.-P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9437 · Cited by 80
An ordinary differential equation model for the multistep transformation to cancer
Spencer, S. L., Berryman, M. J., Garcı́a, J. A., & Abbott, D. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2004.07.006 · Cited by 80
Araya, C. L., Cenik, C., Reuter, J., Kiss, G., Pande, V. S., Snyder, M. P., & Greenleaf, W. J. (2015) · Nature Genetics · doi:10.1038/ng.3471 · Cited by 82
Pagel, K. A., Antaki, D., Lian, A., Mort, M. E., Cooper, D. N., Sebat, J. L., Iakoucheva, L. M., Mooney, S. D., & Predrag Radivojac, A. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007112 · Cited by 82
TICdb: a collection of gene-mapped translocation breakpoints in cancer
Novo, F. J., de Mendíbil, I. O., & Vizmanos, J. L. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-33 · Cited by 81
Brett, B. T., Berquam‐Vrieze, K. E., Nannapaneni, K., Huang, J., Scheetz, T. E., & Dupuy, A. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024668 · Cited by 79
Loss of Connectivity in Cancer Co-Expression Networks
Anglani, R., Creanza, T. M., Liuzzi, V. C., Piepoli, A., Panza, A., Andriulli, A., & Ancona, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087075 · Cited by 79
The use of Gene Ontology terms and KEGG pathways for analysis and prediction of oncogenes
Xing, Z., Chu, C., Chen, L., & Kong, X. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.01.012 · Cited by 79
Sparano, A. M., Quesnelle, K. M., Kumar, M. S., Wang, Y., Sylvester, A. J., Feldman, M. D., Sewell, D. A., Weinstein, G. S., & Brose, M. S. (2006) · The Laryngoscope · doi:10.1097/01.mlg.0000205141.54471.7f · Cited by 79
Structure-based prediction of insertion-site preferences of transposons into chromosomes
Geurts, A. M., Hackett, C. S., Bell, J. B., Bergemann, T. L., Collier, L. S., Carlson, C. M., Largaespada, D. A., & Hackett, P. B. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl301 · Cited by 80
Jian, M., Ren, L., He, G., Lin, Q., Tang, W., Chen, Y., Chen, J., Liu, T., Ji, M., Wei, Y., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02407-8 · Cited by 78
Analyzing genes using closing and replicating circles
Nilsson, M. F., Dahl, F., Larsson, C., Gullberg, M. T., & Stenberg, J. (2005) · Trends in biotechnology · doi:10.1016/j.tibtech.2005.12.005 · Cited by 78
ChimerDB 2.0—a knowledgebase for fusion genes updated
Kim, P., Yoon, S., Kim, N., Lee, S., Ko, M., Lee, H., Kang, H., Kim, J., & Lee, S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp982 · Cited by 78
Pareja, F. G., Geyer, F. C., Kumar, R., Selenica, P., Piscuoglio, S., Ng, C. K. Y., Burke, K. A., Edelweiss, M., Murray, M. P., Brogi, E., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0042-6 · Cited by 78
Copy number variations and cancer susceptibility
Shlien, A., & Malkin, D. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328333dca4 · Cited by 77
RetractedZhou, S., Huang, Y., Liu, H., Zhou, X., Yuan, M., Hou, F., Wang, L., & Jiang, W. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.018 · Cited by 78
Pereira, B., Chen, C. T., Goyal, L., Walmsley, C. S., Pinto, C. J., Baiev, I., Allen, R., Henderson, L. E., Saha, S. K., Reyes, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23394-4 · Cited by 78
Genome Modeling System: A Knowledge Management Platform for Genomics
Griffith, M., Griffith, O. L., Smith, S. M., Ramu, A., Callaway, M. B., Brummett, A. M., Kiwala, M. J., Coffman, A. C., Regier, A., Oberkfell, B., et al. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004274 · Cited by 80
Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma
Nagel, S., Leich, E., Quentmeier, H., Meyer, C., Kaufmann, M., Drexler, H. G., Zettl, A., Rosenwald, A., & MacLeod, R. (2007) · Leukemia · doi:10.1038/sj.leu.2405028 · Cited by 77
Cancer-Associated Loss-of-Function Mutations Implicate DAPK3 as a Tumor-Suppressing Kinase
Brognard, J., Zhang, Y.-W., Puto, L. A., & Hunter, T. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3543 · Cited by 77
Andersson, A., Edén, P., Lindgren, D., Nilsson, J. S., Lassen, C., Heldrup, J., Fontes, M., Borg, Å., Mitelman, F., Johansson, B., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403749 · Cited by 77
Bennett, J. A., Weigelt, B., Chiang, S., Selenica, P., Chen, Y., Bialik, A., Bi, R., Schultheis, A. M., Lim, R. S., Ng, C. K. Y., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.56 · Cited by 78
HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncologyPreprint
Shrestha, R., Hodzic, E., Sauerwald, T., Dao, P., Wang, K., Yeung, J., Anderson, S. A., Vandin, F., Haffari, G., Collins, C. C., et al. (2017) · Genome Research · doi:10.1101/gr.221218.117 · Cited by 77
Chen, J., & Zhang, S. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw059 · Cited by 76
Tumor diversity and the trade-off between universal cancer tasks
Hausser, J., Székely, P., Bar, N., Zimmer, A., Sheftel, H., Caldas, C., & Alon, U. (2019) · Nature Communications · doi:10.1038/s41467-019-13195-1 · Cited by 78
Lee, J. W., Figeys, D., & Vasilescu, J. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)96010-2 · Cited by 76
Identification of novel hub genes associated with liver metastasis of gastric cancer
Chang, W., Ma, L., Lin, L., Gu, L., Liu, X., Cai, H., Yu, Y., Tan, X., Zhai, Y., Xu, X., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24699 · Cited by 76
The large-scale distribution of somatic mutations in cancer genomes
Hodgkinson, A., Chen, Y., & Eyre‐Walker, A. (2011) · Human Mutation · doi:10.1002/humu.21616 · Cited by 80
Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers
Wen, W., Chen, W., Xiao, N., Bender, R. P., Ghazalpour, A., Tan, Z., Swensen, J. J., Millis, S. Z., Basu, G. D., Gatalica, Z., et al. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.04.003 · Cited by 76
Davé, U. P., Akagi, K., Tripathi, R. M., Cleveland, S. M., Thompson, M. A., Yi, M., Stephens, R. M., Downing, J. R., Jenkins, N. A., & Copeland, N. G. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000491 · Cited by 77
Metadata
- Authors
- Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Institute of Cancer Research (GB)
- Corresponding author
- Stratton, Michael R.
- Venue
- Nature Reviews Cancer
- Published
- 2004-03
- Volume
- 4
- Issue
- 3
- Pages
- 177-183
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2665285
- OpenAlex
- W2102140136
- Cited by
- 3,184
- References
- 44
- Citations by year
- 2026: 13 · 2025: 51 · 2024: 71 · 2023: 134 · 2022: 109 · 2021: 143 · 2020: 166 · 2019: 204 · 2018: 237 · 2017: 190 · 2016: 191 · 2015: 228 · 2014: 201 · 2013: 208 · 2012: 164
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- cancer genes, oncogenes, tumor suppressor, oncogenic mutations, mutation frequency, human genome, protein domains, cancer classification
- MeSH terms
- Genes, Humans, Mutation, Neoplasms, Oncogenes, Genome, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review